Artielle
Latest round
- Series A
Last raised
- Oct 2006
Total raised
- $7M
Investors
- 4
About Artielle
Founded in 2004 and headquartered in San Mateo, US, Artielle is dedicated to the development of biologic treatments with a focus on neuroinflammatory and degenerative diseases.Artielle ImmunoTherapeutics specializes in creating a pioneering platform of biologic drugs aimed at treating various inflammatory and degenerative diseases. The company targets neuroinflammatory conditions, including multiple sclerosis, optic neuritis, and methamphetamine addiction, while also addressing degenerative diseases such as stroke.Artielle ImmunoTherapeutics generates revenue through strategic partnerships and collaborations with healthcare providers and research institutions. The company engages in business-to-business transactions that grant access to its biologic drug products, which are crucial in managing severe inflammatory and degenerative diseases. The company is focused on expanding its market presence in North America and Europe, with ambitions to introduce additional innovative biologic therapies that target chronic and acute conditions by 2015.
Who invested in Artielle
4 investors across 2 rounds
See all investors in Artielle
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Artielle
Who invested in Artielle?
Artielle has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Artielle raised?
Artielle has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Artielle last raise money?
Artielle's most recent round on record is a Series A, in Oct 2006.
What does Artielle do?
Founded in 2004 and headquartered in San Mateo, US, Artielle is dedicated to the development of biologic treatments with a focus on neuroinflammatory and degenerative diseases.
Where is Artielle headquartered?
Artielle is headquartered in San Mateo, US.
Which VCs invest in companies like Artielle?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Artielle's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Artielle? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.